Table of Contents

    Topic review

    X-linked Infantile Spinal Muscular Atrophy

    Subjects: Genetics
    View times: 3
    Submitted by: Bruce Ren
    (This entry belongs to Entry Collection "MedlinePlus ")


    X-linked infantile spinal muscular atrophy is a condition that affects only boys and is characterized by severe muscle weakness and absent reflexes (areflexia).

    1. Introduction

    Affected children often have multiple joint deformities (contractures) from birth that cause joint stiffness (arthrogryposis) and impair movement. In severe cases, affected infants are born with broken bones. The muscle weakness worsens over time; affected children reach some early motor developmental milestones, such as sitting unassisted, but these skills are often lost (developmental regression).

    Additional features of X-linked infantile spinal muscular atrophy include an unusually small chin (micrognathia), abnormal curvature of the spine (scoliosis or kyphosis), and undescended testes (cryptorchidism).

    Weakness of the chest muscles used for breathing often leads to life-threatening breathing problems. Children with X-linked infantile spinal muscular atrophy usually do not survive past early childhood due to respiratory failure, although, in rare cases, affected individuals can survive into adolescence.

    2. Frequency

    X-linked infantile spinal muscular atrophy is thought to be a rare condition; its prevalence is unknown.

    3. Causes

    Mutations in the UBA1 gene cause X-linked infantile spinal muscular atrophy. The UBA1 gene provides instructions for making the ubiquitin-activating enzyme E1. This enzyme is necessary for a process that targets damaged or unneeded proteins to be broken down (degraded) within cells. Protein degradation helps to maintain the proper balance of protein production and breakdown (protein homeostasis) that cells need to function and survive.

    UBA1 gene mutations lead to a decrease in enzyme production or the production of an enzyme with reduced or abnormal function. As a result, damaged or unneeded proteins build up inside cells instead of being degraded, which may damage cells and contribute to cell death. This buildup also disrupts protein homeostasis. Old proteins must be removed before cells can make new proteins. If these damaged or unneeded proteins are not degraded, they can impair normal cell functions by stopping the production of new proteins. An imbalance in protein production and breakdown can ultimately lead to cell death. Specialized nerve cells that control muscle movement (motor neurons) are particularly susceptible to disruptions in cell function, likely due to their large size. Loss of these cells causes many of the signs and symptoms of X-linked infantile spinal muscular atrophy.

    4. Inheritance

    This condition is inherited in an X-linked recessive pattern. The gene associated with this condition is located on the X chromosome, which is one of the two sex chromosomes. In males (who have only one X chromosome), one altered copy of the gene in each cell is sufficient to cause the condition. In females (who have two X chromosomes), a mutation would have to occur in both copies of the gene to cause the disorder. Because it is unlikely that females will have two altered copies of this gene, males are affected by X-linked recessive disorders much more frequently than females. A characteristic of X-linked inheritance is that fathers cannot pass X-linked traits to their sons.

    5. Other Names for This Condition

    • AMCX1
    • arthrogryposis multiplex congenita, distal, X-linked
    • arthrogryposis, X-lined, type I
    • distal X-linked AMC
    • infantile X-linked SMA
    • SMAX2
    • spinal muscular atrophy, infantile X-linked
    • spinal muscular atrophy, X-linked 2
    • spinal muscular atrophy, X-linked lethal infantile
    • X-linked arthrogryposis multiplex congenita
    • X-linked arthrogryposis type I
    • X-linked lethal infantile SMA
    • XL-SMA
    • XLSMA

    The entry is from


    1. Balak CD, Hunter JM, Ahearn ME, Wiley D, D'urso G, Baumbach-Reardon L.Functional characterizations of rare UBA1 variants in X-linked Spinal MuscularAtrophy. F1000Res. 2017 Sep 4;6:1636. doi: 10.12688/f1000research.11878.1.
    2. Dlamini N, Josifova DJ, Paine SM, Wraige E, Pitt M, Murphy AJ, King A, Buk S, Smith F, Abbs S, Sewry C, Jacques TS, Jungbluth H. Clinical and neuropathologicalfeatures of X-linked spinal muscular atrophy (SMAX2) associated with a novelmutation in the UBA1 gene. Neuromuscul Disord. 2013 May;23(5):391-8. doi:10.1016/j.nmd.2013.02.001.
    3. Jędrzejowska M, Jakubowska-Pietkiewicz E, Kostera-Pruszczyk A. X-linked spinalmuscular atrophy (SMAX2) caused by de novo c.1731C>T substitution in the UBA1gene. Neuromuscul Disord. 2015 Aug;25(8):661-6. doi: 10.1016/j.nmd.2015.05.001.
    4. Ramser J, Ahearn ME, Lenski C, Yariz KO, Hellebrand H, von Rhein M, Clark RD, Schmutzler RK, Lichtner P, Hoffman EP, Meindl A, Baumbach-Reardon L. Raremissense and synonymous variants in UBE1 are associated with X-linked infantilespinal muscular atrophy. Am J Hum Genet. 2008 Jan;82(1):188-93. doi:10.1016/j.ajhg.2007.09.009.